Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss

Muscle and Nerve

Volumn 43, Issue 3, 2011, Pages 410-414

  Smith, Ira J ^a   Aversa, Zaira ^a   Hasselgren, Per Olof ^a   Pacelli, Fabio ^b   Rosa, Fausto ^b   Doglietto, Giovan Battista ^b   Bossola, Maurizio ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atrogin 1; Calpain; Cancer; MuRF1; Muscle; Ubiquitin proteasome

Indexed keywords

ATROGIN 1; CALCIUM; CALPAIN; CALPAIN 1; CALPAIN 2; CALPASTATIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE; STOMACH CANCER; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; CALPAIN; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UBIQUITIN; WEIGHT LOSS;

EID: 79951877140     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21893     Document Type: Article

References (34)

1. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793-799.
2. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009;89: 381-410.
3. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002;52:72-91. (Pubitemid 34256834)
4. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancer? Br J Cancer 2004;90:1905-1911.
5. Williams AB, Sun X, Fischer JE, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999;126: 744-750.
6. Khal J, Hine AV, Fearon KC, Dejong CHC, Tisdale MJ. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol 2005;37:2196-2206. (Pubitemid 41206831)
7. Bossola M, Muscaritoli M, Costelli P, Bellantone R, Pacelli F, Busquets S, et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol 2001;280:R1518-1523.
8. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 2003;237:384-389. (Pubitemid 38176454)
9. Jagoe RT, Redfern CP, Roberts RG, Gibson GJ, Goodship TH. Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy. Clin Sci 2002;102:353-361. (Pubitemid 34214399)
10. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, et al. Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cachexia. Genome Med 2010;2:1-12.
11. Koohmaraie M. Ovine skeletal muscle multicatalytic proteinase complex (proteasome): purification, characterization, and comparison of its effects on myofibrils with μ-calpains. J Anim Sci 1992;70: 3697-3708.
12. Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996;271:26690-26697. (Pubitemid 26359075)
13. Dahlmann B, Rutschmann M, Reinauer H. Effect of starvation or treatment with corticosterone on the amount of easily releasable myofilaments in rat skeletal muscles. Biochem J 1986;234:659-664. (Pubitemid 16028392)
14. Williams AB, DeCourten-Myers GM, Fischer JE, Luo G, Sun X, Hasselgren PO. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 1999;13:1435-1443.
15. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731-801. (Pubitemid 36828925)
16. Tidball JG, Spencer MJ. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 2002;545:819-828. (Pubitemid 36024422)
17. Wei W, Fareed M, Evenson A, Menconi M, Yang H, Petkova V, et al. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3. Am J Physiol 2005; 288:R580-590.
18. Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, et al. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol 2006;290:R1589-1597.
19. Smith IJ, Alamdari N, O'Neal P, Gonnella P, Aversa Z, Hasselgren PO. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Int J Biochem Cell Biol 2010;42:701-711.
20. Chomzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159. (Pubitemid 17064313)
21. Bodine SC, Latres E, Baumheuter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-1708. (Pubitemid 33104839)
22. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001;98:14440-14445. (Pubitemid 33121410)
23. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004;18:39-51. (Pubitemid 38076464)
24. Busquets S, García-Martínez C, Alvarez B, Carbó N, López-Soriano FJ, Argilés JM. Calpain-3 gene expression is decreased during experimental cancer cachexia. Biochim Biophys Acta 2000;1475:5-9. (Pubitemid 30259232)
25. Costelli P, DeTullio R, Baccino FM, Melloni E. Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 2001;84:946-950. (Pubitemid 32385838)
26. Costelli P, Bossola M, Muscaritoli M, Grieco G, Bonelli G, Bellantone R, et al. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Br J Cancer 2001;84:946-950.
27. Baracos V, Greenberg RE, Goldberg AL. Influence of calcium and other divalent cations on protein turnover in rat skeletal muscle. Am J Physiol 1986;250:E702-710.
28. Smith IJ, Dodd SL. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp Physiol 2007;92:561-573. (Pubitemid 46608406)
29. Abdeen O, Pandol SJ, Burton DW, Deftos LJ. Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia. Am J Gastroenterol 1995;90:1864-1867.
30. Hasselgren PO, Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001; 233:9-17.
31. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004;287:C834-C843.
32. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004;113:115-123. (Pubitemid 38541638)
33. Russell ST, Siren PM, Siren MJ, Tisdale MJ. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate. Cancer Chemother Pharmacol 2009;64:517-527.
34. Bossola M, Mirabella M, Ricci E, Costelli P, Pacelli F, Tortorelli AP, et al. Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss. Int J Biochem Cell Biol 2006;38:1561-1570. (Pubitemid 43729296)